SCHEMBL2399003

SCHEMBL2399003

O=C(c1ncn(-c2cc(Cl)c(O)c(Cl)c2)n1)N(Cc1ccccc1)Cc1ccc(Cl)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.48
NOTUM Q6P988 1/20 0.44
LIMK1 P53667 1/20 0.38
LIMK2 P53671 1/20 0.38
MAPT P10636 3/20 0.37
POLB P06746 1/20 0.37
ABCB1 P08183 1/20 0.37
TP53 P04637 1/20 0.37
RPA1 P27694 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
HSD17B13 Q7Z5P4 2/20 0.36
ENPP2 Q13822 1/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2215745 0.90 NOTUM (0.48) CYP2C19NOTUMPSEN1PSEN2APH1B
SCHEMBL2398024 0.89 NOTUM (0.41) CYP2C19NOTUMMAPTHSD17B13
SCHEMBL2218692 0.88 HDAC1 (0.42) CYP2C19NOTUMMAPTPOLBABCB1
SCHEMBL2213849 0.88 LPAR1 (0.42) CYP2C19NOTUMTSHR
SCHEMBL2214597 0.87 NR1H4 (0.39) CYP2C19NOTUMMAPTPOLBABCB1
SCHEMBL2399030 0.86 ALKBH5 (0.44) MAPTHSD17B13
SCHEMBL2399545 0.86 NOTUM (0.43) CYP2C19NOTUMSIGMAR1ENPP2
SCHEMBL2220730 0.85 TRPM8 (0.41) HSD17B13
SCHEMBL2399668 0.84 NOTUM (0.43) CYP2C19NOTUMHSD17B13ENPP2SMN1; SMN2
SCHEMBL2399391 0.83 SLC6A9 (0.44) ABCB1HSD17B13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110237528-A1 COMPOSITIONS AND METHODS COMPRISING IMIDAZOLE AND TRIAZOLE DERIVATIVES INSTITUTE FOR ONEWORLD HEALTH (US) 2011-09-29 US claimed
US-20110237528-A1 COMPOSITIONS AND METHODS COMPRISING IMIDAZOLE AND TRIAZOLE DERIVATIVES INSTITUTE FOR ONEWORLD HEALTH (US) 2011-09-29 US disclosed
US-20110237528-A1 COMPOSITIONS AND METHODS COMPRISING IMIDAZOLE AND TRIAZOLE DERIVATIVES INSTITUTE FOR ONEWORLD HEALTH (US) 2011-09-29 US disclosed
US-20110237528-A1 COMPOSITIONS AND METHODS COMPRISING IMIDAZOLE AND TRIAZOLE DERIVATIVES INSTITUTE FOR ONEWORLD HEALTH (US) 2011-09-29 US disclosed
US-20100144733-A1 Compounds, compositions and methods comprising heteroaromatic derivatives INSTITUTE FOR ONEWORLD HEALTH 2010-06-10 US disclosed
US-20100144733-A1 Compounds, compositions and methods comprising heteroaromatic derivatives INSTITUTE FOR ONEWORLD HEALTH 2010-06-10 US disclosed
US-20100144733-A1 Compounds, compositions and methods comprising heteroaromatic derivatives INSTITUTE FOR ONEWORLD HEALTH 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144733-A1 Compounds, compositions and methods comprising heteroaromatic derivatives CFTR, PKD1, PKD2 CYP2C19 1247/4885NOTUM 3691/4885LIMK1 3558/4885
US-20110237528-A1 COMPOSITIONS AND METHODS COMPRISING IMIDAZOLE AND TRIAZOLE DERIVATIVES CFTR, PKD1, PKD2 CYP2C19 909/4885NOTUM 3951/4885LIMK1 3199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.